Literature DB >> 31312031

Restriction of HIV-1 and other retroviruses by TRIM5.

Barbie K Ganser-Pornillos1, Owen Pornillos2.   

Abstract

Mammalian cells express a variety of innate immune proteins - known as restriction factors - which defend against invading retroviruses such as HIV-1. Two members of the tripartite motif protein family - TRIM5α and TRIMCyp - were identified in 2004 as restriction factors that recognize and inactivate the capsid shell that surrounds and protects the incoming retroviral core. Research on these TRIM5 proteins has uncovered a novel mode of non-self recognition that protects against cross-species transmission of retroviruses. Our developing understanding of the mechanism of TRIM5 restriction underscores the concept that core uncoating and reverse transcription of the viral genome are coordinated processes rather than discrete steps of the post-entry pathway of retrovirus replication. In this Review, we provide an overview of the current state of knowledge of the molecular mechanism of TRIM5-mediated restriction, highlight recent advances and discuss implications for the development of capsid-targeted antiviral therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31312031      PMCID: PMC6858284          DOI: 10.1038/s41579-019-0225-2

Source DB:  PubMed          Journal:  Nat Rev Microbiol        ISSN: 1740-1526            Impact factor:   60.633


  161 in total

1.  TRIM5α-Mediated Ubiquitin Chain Conjugation Is Required for Inhibition of HIV-1 Reverse Transcription and Capsid Destabilization.

Authors:  Edward M Campbell; Jared Weingart; Paola Sette; Silvana Opp; Jaya Sastri; Sarah K O'Connor; Sarah Talley; Felipe Diaz-Griffero; Vanessa Hirsch; Fadila Bouamr
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

2.  Hexagonal assembly of a restricting TRIM5alpha protein.

Authors:  Barbie K Ganser-Pornillos; Viswanathan Chandrasekaran; Owen Pornillos; Joseph G Sodroski; Wesley I Sundquist; Mark Yeager
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

3.  Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells.

Authors:  Ryuta Sakuma; Amber A Mael; Yasuhiro Ikeda
Journal:  J Virol       Date:  2007-07-03       Impact factor: 5.103

Review 4.  HIV-1 capsid: the multifaceted key player in HIV-1 infection.

Authors:  Edward M Campbell; Thomas J Hope
Journal:  Nat Rev Microbiol       Date:  2015-08       Impact factor: 60.633

5.  Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid.

Authors:  T R Gamble; F F Vajdos; S Yoo; D K Worthylake; M Houseweart; W I Sundquist; C P Hill
Journal:  Cell       Date:  1996-12-27       Impact factor: 41.582

6.  Structural insight into HIV-1 capsid recognition by rhesus TRIM5α.

Authors:  Haitao Yang; Xiaoyun Ji; Gongpu Zhao; Jiying Ning; Qi Zhao; Christopher Aiken; Angela M Gronenborn; Peijun Zhang; Yong Xiong
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

7.  Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection.

Authors:  Xiaolu Wu; Jenny L Anderson; Edward M Campbell; Ajith M Joseph; Thomas J Hope
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-28       Impact factor: 11.205

Review 8.  Fuzziness in Protein Interactions-A Historical Perspective.

Authors:  Monika Fuxreiter
Journal:  J Mol Biol       Date:  2018-02-23       Impact factor: 5.469

9.  Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1.

Authors:  Felipe Diaz-Griffero; Nick Vandegraaff; Yuan Li; Kathleen McGee-Estrada; Matthew Stremlau; Sohanya Welikala; Zhihai Si; Alan Engelman; Joseph Sodroski
Journal:  Virology       Date:  2006-05-02       Impact factor: 3.616

10.  Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.

Authors:  Charles R Langelier; Virginie Sandrin; Debra M Eckert; Devin E Christensen; Viswanathan Chandrasekaran; Steven L Alam; Christopher Aiken; John C Olsen; Alak Kanti Kar; Joseph G Sodroski; Wesley I Sundquist
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

View more
  41 in total

1.  To TRIM or not to TRIM: the balance of host-virus interactions mediated by the ubiquitin system.

Authors:  Adam Hage; Ricardo Rajsbaum
Journal:  J Gen Virol       Date:  2019-12       Impact factor: 3.891

Review 2.  TRIM proteins in autophagy: selective sensors in cell damage and innate immune responses.

Authors:  Martina Di Rienzo; Alessandra Romagnoli; Manuela Antonioli; Mauro Piacentini; Gian Maria Fimia
Journal:  Cell Death Differ       Date:  2020-01-22       Impact factor: 15.828

Review 3.  The pyrin inflammasome and the Yersinia effector interaction.

Authors:  Haleema S Malik; James B Bliska
Journal:  Immunol Rev       Date:  2020-07-28       Impact factor: 12.988

Review 4.  Updating on Roles of HIV Intrinsic Factors: A Review of Their Antiviral Mechanisms and Emerging Functions.

Authors:  Sudarat Hadpech; Sutpirat Moonmuang; Koollawat Chupradit; Umpa Yasamut; Chatchai Tayapiwatana
Journal:  Intervirology       Date:  2021-08-31       Impact factor: 2.294

Review 5.  The Restrictome of Flaviviruses.

Authors:  Lionel Berthoux
Journal:  Virol Sin       Date:  2020-03-09       Impact factor: 4.327

6.  Human TRIM5α senses and restricts LINE-1 elements.

Authors:  Bianca Volkmann; Sabine Wittmann; Justine Lagisquet; Janina Deutschmann; Kristin Eissmann; James J Ross; Brigitte Biesinger; Thomas Gramberg
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-10       Impact factor: 11.205

7.  Target-induced clustering activates Trim-Away of pathogens and proteins.

Authors:  Jingwei Zeng; Ana Filipa Santos; Aamir S Mukadam; Mariana Osswald; David A Jacques; Claire F Dickson; Stephen H McLaughlin; Christopher M Johnson; Leo Kiss; Jakub Luptak; Nadine Renner; Marina Vaysburd; William A McEwan; Eurico Morais-de-Sá; Dean Clift; Leo C James
Journal:  Nat Struct Mol Biol       Date:  2021-02-25       Impact factor: 15.369

8.  Antibodies against human endogenous retrovirus K102 envelope activate neutrophils in systemic lupus erythematosus.

Authors:  Maria Tokuyama; Bronwyn M Gunn; Arvind Venkataraman; Yong Kong; Insoo Kang; Tasfia Rakib; Michael J Townsend; Karen H Costenbader; Galit Alter; Akiko Iwasaki
Journal:  J Exp Med       Date:  2021-05-21       Impact factor: 14.307

9.  TRIM7 inhibits enterovirus replication and promotes emergence of a viral variant with increased pathogenicity.

Authors:  Wenchun Fan; Katrina B Mar; Levent Sari; Ilona K Gaszek; Qiang Cheng; Bret M Evers; John M Shelton; Mary Wight-Carter; Daniel J Siegwart; Milo M Lin; John W Schoggins
Journal:  Cell       Date:  2021-05-31       Impact factor: 66.850

Review 10.  Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses.

Authors:  Amit Gaba; Ben Flath; Linda Chelico
Journal:  Viruses       Date:  2021-06-07       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.